Кардиаск Drug photo

The description is actual on 19.08.2014

  • Latin name: CardiASK
  • ATH code: B01AC06
  • Active ingredient: Acetylsalicylic acid (Acidum acetylsalicylicum)
  • Producer: Kanonfarm (Russia)


Active agent of drug — acetylsalicylic acid.

In addition it contains the following additional components: stearic acid, lactoses monohydrate, povidone, MKTs, starch corn, the castor oil hydrogenated the twin 80.

The film cover of medicine consists from: methacrylic acid and copolymer of ethyl acrylate, kopovidon, talc, macrogoal and copolymer of polyvinyl alcohol, triethyl citrate, titanium dioxide.

Release form

Is issued in the form of tablets on 50 and 100 mg.

Pharmacological action

Has anti-aggregation effect. Besides, possesses antiinflammatory, analgeziruyushchy and febrifugal properties.

Pharmacodynamics and pharmacokinetics

The irreversible inactivation of TsOG-1 interferes with synthesis of A2 thromboxane and reduces aggregation of thrombocytes.

Drug is exhausted in a small bowel. The maximum concentration of active agent in a blood plasma comes in 3 hours after use. It is partially split in a liver with formation of inactive metabolites.

This medicine through kidneys in an invariable look, and also in the form of metabolites is removed. An elimination half-life – 15 minutes for active agent and 3 hours for metabolites.

Indications to use of Kardiask

Indications to use of Kardiask the following:


Drug is not recommended to be used at:

  • gastrointestinal tract canker;
  • problems with work of kidneys;
  • to bronchial asthma;
  • hypersensitivity to one or several components of medicine;
  • bleedings in a gastrointestinal tract;
  • hemorrhagic diathesis;
  • liver and renal failure;
  • pregnancies;
  • lactations;
  • children's age.

Side effects

At use of drug such side effects as nausea, vomiting, heartburnabdominal pains, dizziness, a headache, decrease in hearing, a sonitus were noted. In rare instances there were stomach ulcer and a small bowel, and also disturbance in work of a liver with increase of activity of transaminases, bleedings in a gastrointestinal tract, anemia.

Perhaps also developing of rash, small tortoiseshell, allergic rhinitis, acute anaphylaxis, skin itch, Quincke's edema, hypostasis mucous nose and cardiorespiratory distress syndrome.

Application instruction of Kardiask

Drug is used inside before meal. Tablets should be washed down with a large amount of water.

The application instruction of Kardiask provides the individual mode of dosing:

  • for adults the one-time dosage can be from 150 mg to 2 g, and daily, in turn — from 150 mg to 8 g. Drug of 2-6 times a day is accepted;
  • for children a one-time dosage – 10-15 mg on kilogram. A pill to 5 times a day is taken;
  • at an acute myocardial infarction, and also for the purpose of prevention of a stroke and disturbances of cerebral circulation recommend to accept 100 mg of drug a day.

The final dosage and the scheme of the use needs to be coordinated with the doctor. The application instruction of Kardiask reports that drug is intended for long reception. Course duration is also determined by the doctor.


At overdose emergence of nausea, a sonitus, dizziness, vomiting, deterioration in hearing, confusion of consciousness is possible. At very high doses fever, ketoacidosis, a coma, the expressed hypoglycemia, hyperventilation, a respiratory alkalosis, and also cardiovascular and respiratory insufficiency develops.

Symptoms of overdose are especially shown at patients at advanced age.

At moderately severe overdose the dose of drug is reduced. At heavy overdose of the patient it is necessary to hospitalize and carry out the emergency therapy immediately. Appoint a gastric lavage and absorbent carbon, the alkaline and forced alkaline diuresis (it is necessary to achieve indicators rn 7,5-8), infusional therapy, definition of indicators of acid-base equilibrium, a hemodialysis. Symptomatic treatment.


This medicine strengthens effect of the following drugs:

Side effects from bodies of a hemopoiesis can appear at a combination of Kardiask to the Methotrexate, anticoagulants, antiagregant, trombolitika.

Drug also reduces effect of uricosuric medicines: Benzbromarona, Diuretics, APF inhibitors.

Terms of sale

It is authorized to release medicine in drugstores bezretsepturno.

Storage conditions

It is necessary to store drug in the unavailable to children, dry and well protected from penetration of light place. Optimum temperature – is not above 25 °C.

Period of validity

The period of validity makes 2 years.


Kardiask has the following analogs:


About drug Kardiask generally positive. At forums many are interested whether this means, than its analogs is more effective. There is no definite answer to this question as there is a lot of similar drugs and all of them have the features.

Reviews of specialists of Kardiask also positive. Very often they appoint it for prevention of a myocardial infarction, a stroke and thrombosis of various etiology.


  • Kardiask 50 mg No. 30 of a tabletkikanonfarm production closed joint stock company
  • Kardiask 100 mg No. 30 of a tabletkikanonfarm production closed joint stock company
  • Kardiask 50 mg No. 60 of a tabletkikanonfarm production closed joint stock company
  • Kardiask 100 mg No. 60 of a tabletkikanonfarm production closed joint stock company

Drugstore of IFC

  • Kardiask tbl p / about 100 mg No. 30 **, Kanonfarm Production Zaorossiya
  • Kardiask tbl p/pl/o 50 mg No. 30 *, Kanonfarm Production Zaorossiya
to show still
Section: Cardiovascular
PAY ATTENTION! Information on drugs on the website is help generalizing, collected from public sources and can form the basis for making decision on use of medicines it is not aware of treatment. Before medicine use Kardiask surely consult with the attending physician.